Your account is not claimed yet. You can sign up with ORCID to claim your account.

Montse Sanchez-Cespedes (M Sanchez-Cespedes)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 3

Top Topics

Lymph Node Metastasis

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Nature communications

Josep Carreras Leukemia Research Institute

University of Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Josep Carreras Leukemia Research Institute Jun 1o 2019

Spain

Group Leader

Education History

University of Barcelona

Spain

PHD

Publications

Octavio A Romero, Andrea Vilarrubi, Juan J Alburquerque-Bejar, Antonio Gómez, Alvaro Andrades, Deborah Trastulli, Eva Pros, Fernando Setien, Sara Verdura, Lourdes Farre, Juan F Martín-Tejera, Paula Llabata, Ana Oaknin, Maria Saigí, Josep M Piulats, Xavier Matias-Guiu, Pedro P Medina, August Vidal Bel, Alberto Villanueva, Montse Sanchez-Cespedes
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade. Nature communications 12 (1) (2021)
Paula Llabata, Manuel Torres-Diz, Antonio Gómez, Laureano Tomás-Daza, Octavio A Romero, Joaquím Grego-Bessa, Pere Llinas-Arias, Alfonso Valencia, Manel Esteller, Biola-Maria Javierre, Xiaoyang Zhang, Montse Sanchez-Cespedes
MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex. Proceedings of the National Academy of Sciences of the United States of America 118 (37) (2021)
M Saigi, A McLeer-Florin, E Pros, E Nadal, E Brambilla, Montse Sanchez-Cespedes
Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20 (7) (2017)